4Chernish RN,AaronSD.Approach to resistant gramnegative bacterial pulmonary infections in patients with cystic fibrosis[ J].Curr Opin Pulm Med,2003,9(6):509.
二级参考文献12
1Fung-Tomc JC,Gradelski E,Valera L,et al.Synergistic activity of the novel des-fluoro(6)quinolone,garenoxacin(BMS-284756),in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species[J].Int J Antimicrob Agents,2002,20(1
2Haussler S,Lehmann C,Breselge C,et al.Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex[J].Eur J Clin Microbiol Infect Dis,2003,22(4):249-253.
3Coenye T,Vandamme P,Govan JR, et al.Taxonomy and identification of the Burkholderia cepacia complex[J].J Clin Microbiol,2001,39:3427-3436.
4Allan ND,Beveridge TJ.Gentamicin delivery to Burkholderia cepacia group llla strains viamembrane vesicles from Pseudomonas aeruginosa PAO1[J].Antimicrob Agents Chemother.2003,47(9):2962-2965.
5Crowley D,Daly M,Lucey B,et al.Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland[J].J APPl Microbiol,2002,92(5):992-1004.
6Saika T,Kobayashi I,Hasegawa M,et al.Antimicrobial resistance and DNA-Afingerprinting pattern of Burkholderia cepacia blood isolates[J].J Infect Chemother,200,8(4):341-344.
8Smith DL,Gumery LB,Smith EG,et al.Epidemic of Pseudomonas cepacia in an adult cysticfibrosis unit;Evidence of person to person transmission[J].J Clin Microbiol,1993,31:3017.
9Hancock RE.Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative gram-negative bacteria[J].Clin Infect Dis,1998,27,Suppl(1):S93-99.
